Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Madrigal Pharmaceuticals, Inc. (MDGL)

512.65 -1.14 (-0.22%)
At close: June 26 at 4:00:00 PM EDT
512.66 +0.01 (+0.00%)
After hours: June 26 at 4:30:12 PM EDT
Trade MDGL on Coinbase
Chart Range Bar
Loading chart for MDGL
  • Previous Close 513.79
  • Open 517.66
  • Bid 512.27 x 100
  • Ask 520.72 x 800
  • Day's Range 505.63 - 532.33
  • 52 Week Range 284.02 - 615.00
  • Volume 2,500,271
  • Avg. Volume 330,870
  • Market Cap (intraday) 11.819B
  • Beta (5Y Monthly) -1.06
  • PE Ratio (TTM) --
  • EPS (TTM) -13.48
  • Earnings Date (est.) Aug 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 678.71

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

www.madrigalpharma.com

915

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 6/26/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MDGL
11.97%
S&P 500 (^GSPC)
7.43%

1-Year Return

MDGL
71.16%
S&P 500 (^GSPC)
19.75%

3-Year Return

MDGL
117.94%
S&P 500 (^GSPC)
69.89%

5-Year Return

MDGL
408.53%
S&P 500 (^GSPC)
71.79%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 311.34M
Earnings -40.09M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-100M
0
100M
200M
300M

Analyst Insights

View More

Analyst Price Targets

542.00
678.71 Average
512.65 Current
964.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/11/2026
Analyst B of A Securities
Rating Action Maintains
Rating Neutral
Price Action Lowers
Price Target 550 -> 542

Statistics

View More

Valuation Measures

Annual
As of 6/26/2026
  • Market Cap

    11.82B

  • Enterprise Value

    11.35B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.26

  • Price/Book (mrq)

    21.75

  • Enterprise Value/Revenue

    10.03

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -27.32%

  • Return on Assets (ttm)

    -17.62%

  • Return on Equity (ttm)

    -49.35%

  • Revenue (ttm)

    1.13B

  • Net Income Avi to Common (ttm)

    -309.44M

  • Diluted EPS (ttm)

    -13.48

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    812.77M

  • Total Debt/Equity (mrq)

    63.91%

  • Levered Free Cash Flow (ttm)

    -156.4M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

512.65 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 01/27/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/21/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/28/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/21/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: